Design, synthesis, and preclinical evaluation of 11C/18F-labeled inhibitors for RIPK1 PET imaging
Authors:
- 6 September 2024
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 279, 116851
Abstract
No abstract availableKeywords
Funding Information
- Sichuan University West China hospital
This publication has 32 references indexed in Scilit:
- Development and Pharmacochemical Characterization Discover a Novel Brain-Permeable HDAC11-Selective Inhibitor with Therapeutic Potential by Regulating Neuroinflammation in MiceJournal of Medicinal Chemistry, 2023
- Radiosynthesis and characterization of a carbon-11 PET tracer for receptor-interacting protein kinase 1Nuclear Medicine and Biology, 2022
- Potent and Selective RIPK1 Inhibitors Targeting Dual‐Pockets for the Treatment of Systemic Inflammatory Response Syndrome and SepsisAngewandte Chemie International Edition, 2021
- Visualization of Receptor-Interacting Protein Kinase 1 (RIPK1) by Brain Imaging with Positron Emission TomographyJournal of Medicinal Chemistry, 2021
- Design, Synthesis, and Evaluation of Thienodiazepine Derivatives as Positron Emission Tomography Imaging Probes for Bromodomain and Extra-Terminal Domain Family ProteinsJournal of Medicinal Chemistry, 2021
- Caspase-8-Dependent Inflammatory Responses Are Controlled by Its Adaptor, FADD, and NecroptosisImmunity, 2020
- TBK1 Suppresses RIPK1-Driven Apoptosis and Inflammation during Development and in AgingCell, 2018
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Detailed analysis of grid‐based molecular docking: A case study of CDOCKER—A CHARMm‐based MD docking algorithmJournal of Computational Chemistry, 2003
- TNF-Dependent Recruitment of the Protein Kinase RIP to the TNF Receptor-1 Signaling ComplexImmunity, 1996